Prostate Cancer Foundation 2018 Scientific Retreat

Prostate Cancer Foundation 2018 Scientific Retreat

INTERVIEW WITH ANDREA MIYAHIRA
The Prostate Cancer Foundation: A Discussion with Andrea Miyahira

VIEW ALL PCF VIDEOS

Prostate Cancer Foundation 2018 Scientific Retreat

Prostate Cancer Foundation 2018 Scientific Retreat

INTERVIEW WITH KENNETH PIENTA
The Process of Metastasis in Prostate Cancer

VIEW ALL PCF VIDEOS

European Society for Medical Oncology 2018 Congress

European Society for Medical Oncology 2018 Congress

INTERVIEW WITH FRED SAAD
A Renewed Analysis of ERA 223

VIEW ALL ESMO VIDEOS

Featured Videos

SAN FRANCISCO, CA USA (UroToday.com) - Dr. Timur Mitin presented an abstract comparing outcomes in complete and near-complete responses (CR and nCR) in bladder preservation protocols.

Previous randomized studies in bladder preservation protocols necessitated a radical cystectomy for patients with residual disease after induction therapy. However, pathological analyses of these specimens showed that many of the patients had minimal residual disease. This prompted the RTOG to determine if such minimal residual disease can be safely managed without cystectomy.

gucancerssympalt thumbDr. Mitin presented the data from RTOG 9906 which was a single-arm prospective trial of bladder preservation with twice daily radiation and radio-sensitizing chemotherapy, and also data from RTOG 0233 which was a randomized controlled trial assessing two different chemotherapy regimens, in addition to radiation. He compared the outcomes of CR (n=101) and nCR (n=18) patients and showed that there was no significant difference in recurrence, muscle-invasive recurrence, salvage cystectomy rates, or overall survival. This suggests that patients with non-muscle invasive disease, after bladder preservation protocols, may be safely observed and managed endoscopically.

Highlights of a presentation by Timur Mitin, MD, PhD at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

Massachusetts General Hospital, Boston, MA USA

Written by Phillip Abbosh, MD, PhD, medical writer for UroToday.com


View Full 2014 GU Cancers Symposium Coverage

 

Clinical Trials
Searchable data base of currently enrolling clinical trials
Journals
Publications focusing on urological cancer treatments through original commentary & articles
Everyday Urology Volume 3 Issue 2

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

@UroToday
Calendar
Upcoming educational events
November 23-25, 2018 / European Society for Medical Oncology Asia 2018 Congress
European Society for Medical Oncology Asia 2018 Congress
November 25-30, 2018 / RSNA 2018 Annual Meeting
RSNA 2018 Annual Meeting
December 13-16, 2018 / ESMO Immuno-Oncology Congress 2018
ESMO Immuno-Oncology Congress 2018